FDA Letter API

Cosmax Nbt Usa, Inc.

Letter data

Company
Cosmax Nbt Usa, Inc.
Recipient
Mr. Jay Ahn | CEO | Cosmax Nbt Usa, Inc. | 3366 Miller Park S | Garland | , | TX | 75042-7771 | United States
Issue date
2023-11-30
Posted date
Not available
FDA office
Division of Human and Animal Food Operations West III
Subject
Not available
Product
Dietary Supplements
CMS ID
615933
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Cosmax Nbt Usa, Inc. MARCS-CMS 615933 — November 30, 2023 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: UPS Overnight Product: Dietary Supplements Recipient: Recipient Name Mr. Jay Ahn Recipient Title CEO Cosmax Nbt Usa, Inc. 3366 Miller Park S Garland , TX 75042-7771 United States Issuing Office: Division of Human and Animal Food Operations West III United States Dear Mr. Ahn: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS 615933 dated May 03, 2023) issued following an inspection of your beverage manufacturing and distribution facility, located at 3350 Marquis Dr., Garland, TX 75042-7771. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Jessica E. Havranek Director, Compliance Branch Human & Animal Food Operations, West Division 3 Content current as of: 12/05/2023 Regulated Product(s) Dietary Supplements